Immune response to intracellular pathogens Flashcards
characteristics of intracellualr pathogen
- Take advantage of the environment inside cells than extracellular pathogens
- typically equipped to gain access to human tissues without the need for a scratch or abrasion, and have specific mechanisms to enter cells.
- developed strategies to colonise macrophages that would normally eat and destroy them, and can instead proliferate inside them.
what are the two types of intracellular microbes
- Obligate intracellular pathogens
• cannot reproduce outside the host cell
• require the cells’ metabolic energy and biosynthetic processes for their proliferation.
• Since they still need to leave the cell to spread, they typically have a distinct extracellular form to survive in the outside environment too
• often inactive, such as virus particles, bacterial spores, or encapsulated cells with a very low level of metabolic activity.- Facultative intracellular pathogens
• can survive and proliferate in the extracellular environment
• but they can also invade host cells
- Facultative intracellular pathogens
How do the body deals with intracellular pathogens
- Starts by detecting PAMPs (DAMPs) in cell resulting in cell signalling that tells the immune system which weapons to arm,
- which can tell the cellular innate immune system (NK cells and phagocytes) to destroy and remove the infected cell(s).
- pathogen’s proteins/peptides can be presented to theadaptive immune system, thereby facilitating the destruction of the pathogen’s cells by cytotoxic T (TC) cells
Three main characteristics that define what immune responses will be effective
- What nucleic acid their genome is made of (DNA or RNA; single or double stranded)
- Whether or not they have a lipid envelope
- Whether they replicate their genome in the cytoplasm or the nucleus
Describe the entry of virus into the cell
virus must first attach itself to a cell surface using a glycoprotein on the virus binding to receptor on cell
For unenveloped virus, virus binding will lead to endocytosis
For enveloped virus, the glycoprotein on the virus cause fusion of viral membrane with cell membrane and allows virus to enter the cytosol without the capsid
After entering the cytosol, virus with RNA will head to cytoplasm while retrovirus and DNa virus will head to nucleus
Action of antibody on virus
antibodies neutralise virus by sticking to glycoprotein on virus, blocking them from binding to virus receptor
enveloped virus avoid detection because the envelope proteins to which antibodies bind are left on the surface of cell when virus envelope fuses with cell membrane
Describe the pathway that senses the cytoplasmic DNA
- When cGAS binds to DNA, it combines ATP with GTP to make a cyclic GMP/AMP molecule,cGAMP
- cGAMP acts as a ’second messenger’ molecule in the cell. cGAMP binds to the proteinSTING, which is located on the membrane of the endoplasmic reticulum (ER)
- STING in turn activates a kinase called TBK1
- that activates interferon response factor 3 (or IRF3)
- which then enters the nucleus and
- activates transcription of type Iinterferons,such asIFN-α subtypes and/or IFN-β.
What problems do sensing viral RNA has and how to solve
very common to find RNA in cytoplasm, and cannot rely on RNA location. Need to recognise features of viral RNA that are not shared by cellular RNAs so use RNA -sensing protein (RIG-l-like receptor) RLR family, when bind to RNA, activates a signalling cascade by driving the multimerisation of mitochondrial protein MAVS
function of RIG-1
can sense short viral RNA in both nucleus and cytoplasm
function of MDAS
sense long double stranded RNA,
describe the sensing RNA pathway
When activated by binding RNA ,both RIG-I and MDA5 assocaite with mitochondrial antiviral signalling protein (MAVS). When multiple MAVS protein are clumped together on mitochondrial membrane by interaction with RIG-I or MDA5, they signal through kinase/phosphorylation cascade to activate IRF3, which is able to enter nucleus and trigger expression of IFNa or IFNb
What are the three types of interferon
- Type I IFNs (including all twelve α-subtypes and IFN-β)
• produced in response to pathogen-induced signals in the infected cells;- Type II IFN (which includes just IFN-γ)
• produced by activated immune cells, and generally signals to modulate the responses of other immune cells; - Type III IFNs (three IFN-λ subtypes)
• structurally related to IL-10 but like type I and II IFNs lead to an antiviral state in cells infected with a virus.
- Type II IFN (which includes just IFN-γ)
Role of interferon in response to intracellular infection signal
- Signalling in response to the interferon can activate and attract cells of immune system
- Non-immune cells can also respond
• IRF7 is activated which turns on whole suite of IFN-stimulated genes (ISGs)
• places the cell in a state of alert: an antiviral state has been established in order to control viral replication upon and infection. - ISGs include antiviral PRRs and restriction factors.
• Restriction factors are cellular gene products which prevent specific pathogen functions
The upregulation of ISgs places cell in an antiviral state
- Non-immune cells can also respond
What is the antiviral state
- Binding of interferon to cell leads to signalling cascade that triggers transcription of genes coding for protein that help fight virus
- As a result of IFN signalling theseISGsare transcriptionally upregulated
- ISGs include antiviral PRRs, components of the immunoproteasome,activatory recptors andrestriction factors.
How do NK cells activate
- NK activation depends on the balance between inhibitory receptors and activating receptors.
- Healthy cells are tolerated as more inhibitory receptors are ligated to the MHC I than activating receptors.
- Missing MHC I (as in tumour cells) promotes killing of the target by NK cells as inhibitory receptors are not bound.
- Upregulation of activating receptors to overwhelm inhibitory receptors, in response to intracellular stress signals, also leads to destruction of the cell.
- However, activating ligands are still not identified.